Limba
Romanian
Romanian
English|
Visilizumab (Anti-CD3), 1mg*25
32.845,19 RON
SKU
SKM_A2816_1mg*25
Visilizumab (Anti-CD3) is a humanized, non-Fc receptor (FcR)-binding IgG2 monoclonal antibody (MoAb) directed against CD3 with potential immunosuppressive activity. Visilizumab has the potential to be used for ulcerative colitis and Crohn's disease research. MW : 144.62 KD.
| Price | 27.601,00 RON (preturile sunt fara TVA) |
|---|---|
| Description |
Visilizumab (Anti-CD3) is a humanized, non-Fc receptor (FcR)-binding IgG2 monoclonal antibody (MoAb) directed against CD3 with potential immunosuppressive activity. Visilizumab has the potential to be used for ulcerative colitis and Crohn's disease research. MW : 144.62 KD. |
